The recurrence rate of bladder cancer is not 100%, and some studies claim that its 1-year tumor recurrence rate is about 30%, while the 2-year recurrence rate is about 60%.
Most of the bladder cancers are non-muscle invasive bladder cancers, and transurethral cystectomy is the main treatment option. However, the postoperative tumor residual rate is not optimistic, and there are also uncertainties about the number of tumors, their sizes, grades, and carcinoma in situ.
Some studies claim that the recurrence and progression rates within 1 year after surgery can reach 15%-61% and 1%-17%, respectively. Surgery combined with bladder intravesical adjuvant perfusion therapy is the main option for the treatment of non-muscle invasive bladder cancer both at home and abroad, which can effectively reduce the recurrence rate and kill the free tumor tissues/cells after surgery.
It has also been claimed that after bladder tumor resection combined with intravesical instillation chemotherapy, its 1-year tumor recurrence rate is about 30%, while the 2-year recurrence rate is about 60%. Among them, tumor pathological grading, pathological type, and patient’s age are closely related to tumor recurrence.
Bladder cancer patients should pay attention to it. If bladder tumor is suspected or diagnosed, it is recommended to go to regular hospitals for comprehensive assessment of the condition, follow the doctor’s instructions to cooperate with the treatment, and choose the appropriate treatment plan so as not to delay the condition.